These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27356023)

  • 21. The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology.
    Filippi M; Rocca MA
    Acta Neurol Belg; 2011 Jun; 111(2):89-98. PubMed ID: 21748926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
    Aharony S; Lam O; Lapierre Y; Corcos J
    Neurourol Urodyn; 2016 Feb; 35(2):174-9. PubMed ID: 25620021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging.
    Rumzan R; Chen X; Li YM
    Chin Med J (Engl); 2012 Jul; 125(13):2361-4. PubMed ID: 22882862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical activity and pediatric multiple sclerosis: Developing a research agenda.
    Yeh EA; Kinnett-Hopkins D; Grover SA; Motl RW
    Mult Scler; 2015 Nov; 21(13):1618-25. PubMed ID: 26447061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
    Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. McArdle Sign: A Specific Sign of Multiple Sclerosis.
    Savoldi F; Nasr Z; Hu W; Schilaty ND; Delgado AM; Mandrekar J; Kaufman KR; Berglund L; Weinshenker BG
    Mayo Clin Proc; 2019 Aug; 94(8):1427-1435. PubMed ID: 31303427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis: a review of existing therapy and future prospects.
    Khan OA
    J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of multiple sclerosis.
    Perrin Ross A
    Am J Manag Care; 2013 Nov; 19(16 Suppl):s301-6. PubMed ID: 24494619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No].
    Edan G
    Rev Neurol (Paris); 2013 Nov; 169(11):864-8. PubMed ID: 24125462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
    Placidi G; Sabatini M; Gallucci M; Sotgiu A
    Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis: a primary care perspective.
    Saguil A; Kane S; Farnell E
    Am Fam Physician; 2014 Nov; 90(9):644-52. PubMed ID: 25368924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L
    Acta Neurol Scand Suppl; 2009; (189):51-7. PubMed ID: 19566500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.